Effectiveness of sirolimus-eluting stent implantation for the treatment of coronary artery disease in octogenarians.
Sirolimus-eluting stent (SES) implantation has been shown to reduce repeat revascularization in various randomized trials. The present study evaluated the outcomes after SES implantation in 46 octogenarian patients. SES implantation in octogenarians appears to be feasible and is associated with very small subsequent need for repeat target vessel revascularization at 1 year.
Erasmus Medical Center, Thoraxcenter, Rotterdam, The Netherlands.
Maniyal
M
Vijayakumar
Pedro A
PA
Lemos
Angela
A
Hoye
Andrew T L
AT
Ong
Jiro
J
Aoki
Gaston Rodriguez
GR
Granillo
Eugene P
EP
McFadden
Georgios
G
Sianos
Sjoerd H
SH
Hofma
Pieter C
PC
Smits
Willem J
WJ
van der Giessen
Pim
P
de Feyter
Ron T
RT
van Domburg
Paul A
PA
Cummins
Patrick W
PW
Serruys
D000368:Aged; D000369:Aged, 80 and over; D015906:Angioplasty, Balloon, Coronary; D019917:Blood Vessel Prosthesis Implantation; D020099:Coated Materials, Biocompatible / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003324:Coronary Artery Disease / Q000628:therapy*; D005260:Female; D005500:Follow-Up Studies; D017052:Hospital Mortality; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D009426:Netherlands; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors / Q000627:therapeutic use; D011183:Postoperative Complications / Q000209:etiology / Q000401:mortality; D020123:Sirolimus / Q000627:therapeutic use*; D015607:Stents; D016896:Treatment Outcome
D020099:Coated Materials, Biocompatible; D007166:Immunosuppressive Agents; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D020123:Sirolimus